D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
1201
Chatham Lodging
CLDT
$348M
| $4.68M | ﹤0.01% |
549,595
-51,088
| -9% | -$435K |
|
|
SAGE
1202
DELISTED
Sage Therapeutics
SAGE
| $4.67M | ﹤0.01% |
647,032
+322,761
| +100% | +$2.33M |
|
1203
Douglas Elliman
DOUG
$241M
| $4.67M | ﹤0.01% |
2,551,997
-71,627
| -3% | -$131K |
|
1204
WD-40
WDFC
$2.86B
| $4.67M | ﹤0.01% |
18,094
+8,738
| +93% | +$2.25M |
|
1205
Weis Markets
WMK
$1.75B
| $4.66M | ﹤0.01% |
67,539
-17,193
| -20% | -$1.19M |
|
1206
Caleres
CAL
$503M
| $4.66M | ﹤0.01% |
140,855
+65,088
| +86% | +$2.15M |
|
1207
Altimmune
ALT
$321M
| $4.65M | ﹤0.01% |
758,004
-4,358
| -0.6% | -$26.8K |
|
1208
Liberty Media Series A
FWONA
$22.5B
| $4.65M | ﹤0.01% |
64,964
+6,009
| +10% | +$430K |
|
1209
Manulife Financial
MFC
$54.2B
| $4.63M | ﹤0.01% |
156,627
-151,400
| -49% | -$4.47M |
|
1210
LeMaitre Vascular
LMAT
$2.09B
| $4.63M | ﹤0.01% |
49,804
+20,329
| +69% | +$1.89M |
|
|
RFAI
1211
RF Acquisition Corp II Ordinary Shares
RFAI
$159M
| $4.63M | ﹤0.01% |
+456,134
| New | +$4.63M |
|
1212
Grand Canyon Education
LOPE
$5.89B
| $4.62M | ﹤0.01% |
32,548
-18,799
| -37% | -$2.67M |
|
1213
Mativ Holdings
MATV
$674M
| $4.61M | ﹤0.01% |
271,297
+159,601
| +143% | +$2.71M |
|
1214
SIGA Technologies
SIGA
$639M
| $4.59M | ﹤0.01% |
680,513
-393,578
| -37% | -$2.66M |
|
1215
NNN REIT
NNN
$8.12B
| $4.59M | ﹤0.01% |
94,557
+69,068
| +271% | +$3.35M |
|
1216
Paylocity
PCTY
$9.36B
| $4.58M | ﹤0.01% |
27,770
-57,942
| -68% | -$9.56M |
|
1217
General Mills
GIS
$26.7B
| $4.58M | ﹤0.01% |
62,011
+6,866
| +12% | +$507K |
|
1218
Ryan Specialty Holdings
RYAN
$6.61B
| $4.57M | ﹤0.01% |
68,860
+35,699
| +108% | +$2.37M |
|
1219
Builders FirstSource
BLDR
$15.8B
| $4.57M | ﹤0.01% |
23,569
-51,751
| -69% | -$10M |
|
1220
BioNTech
BNTX
$23.3B
| $4.55M | ﹤0.01% |
38,345
-30,202
| -44% | -$3.59M |
|
1221
Rayonier Advanced Materials
RYAM
$421M
| $4.55M | ﹤0.01% |
531,940
| – | – |
|
1222
Intapp
INTA
$3.71B
| $4.54M | ﹤0.01% |
94,965
+62,906
| +196% | +$3.01M |
|
1223
Varex Imaging
VREX
$469M
| $4.54M | ﹤0.01% |
380,727
+296,701
| +353% | +$3.54M |
|
1224
BrightView Holdings
BV
$1.32B
| $4.53M | ﹤0.01% |
287,640
-15,624
| -5% | -$246K |
|
1225
InterContinental Hotels
IHG
$18.4B
| $4.52M | ﹤0.01% |
40,941
+18,093
| +79% | +$2M |
|